In a sweeping shift aimed at refocusing its core mission, Reckitt Benckiser Group PLC announced Friday that it has agreed to sell 70% of its Essential Home business—home to iconic brands like Air Wick, Calgon, Woolite, and Cillit Bang—to U.S. private equity giant Advent International LP in a blockbuster $4.8 billion deal.

The British consumer goods titan will retain a 30% minority stake, ensuring continued strategic interest while handing Advent the reins to scale and steer the business independently. The carve-out, which covers over 75 brands across 70 global markets, will transform Essential Home into a standalone force in the home care sector.

Strategic Rebalancing: Reckitt Bets on Health and Hygiene

“This is a major milestone in our journey to becoming a simpler, more focused, world-class consumer health and hygiene company,” said Reckitt CEO Kris Licht, who is helming a bold transformation that has seen the company move away from general household products to concentrate on so-called “powerbrands” like Durex, Dettol, and Gaviscon—which now account for more than 80% of Reckitt’s revenue.

In the reshaped vision, Essential Home—though still profitable—no longer aligns with Reckitt's growth trajectory, prompting the divestment. The move will strengthen the company’s balance sheet, according to analysts, and provide capital flexibility for future investments.

Advent’s Play for Global Brand Domination

Advent will pay up to $1.3 billion in deferred and contingent payments, contingent on performance metrics. Ranjan Sen, Advent’s managing partner, called the acquisition “a unique opportunity to build a focused, scaled platform of globally recognized home-care brands.”

With Advent at the helm, the newly independent Essential Home business is expected to innovate faster, expand deeper into new markets, and aggressively pursue category leadership in air care, pest control, and laundry solutions.

Following closing, Advent will operate Essential Home as a standalone company, with Reckitt providing transitional services, including manufacturing, supply chain, and operational support, to ensure a smooth separation.

Deal Details, Financial Impact, and Shareholder Rewards

The transaction, subject to regulatory approvals, is expected to close by the end of 2025. While the companies did not specify which regulatory bodies are involved, such high-profile cross-border deals typically require clearance in the U.S., U.K., and EU.

Reckitt anticipates $800 million in one-time costs associated with the spin-off, most of which will be paid in 2026. However, the company plans to sweeten the deal for shareholders with a $2.2 billion special dividend drawn from the proceeds—signaling a windfall for investors.

Financial advisers to Reckitt include Goldman Sachs International, Morgan Stanley & Co. International PLC, and Robey Warshaw LLP. Slaughter and May is providing legal counsel. Advent’s legal team was not disclosed as of Friday’s announcement.

Investor Reaction: Analysts Back the Pivot

Market watchers welcomed the news. Derren Nathan, head of equity research at Hargreaves Lansdown, said the move “strengthens Reckitt’s balance sheet,” while Dan Coatsworth, an investment analyst at AJ Bell, noted it supports the ongoing reshaping of the business under Licht’s leadership.

In an era where agility defines success in consumer markets, Reckitt’s divestiture marks a clear pivot—letting go of legacy household names in pursuit of high-growth health and hygiene dominance. Meanwhile, Advent is betting big that what’s essential at home still has room to grow—and conquer.